Sarcopenia y fragilidad en sujetos sometidos a hemodiálisis en un centro de diálisis en el Perú
DOI:
https://doi.org/10.35454/rncm.v2n1.060Palavras-chave:
sarcopenia, fragilidad, SARC-F, escala clínica de fragilidad, diagnóstico de fragilidadResumo
La toxemia urémica, la inflamación y las alteraciones metabólicas de sujetos con enfermedad renal crónica en hemodiálisis favorecen la sarcopenia y fragilidad. El objetivo de este estudio es determinar la prevalencia de sarcopenia y fragilidad en sujetos sometidos a hemodiálisis en Perú.
Downloads
Referências
Carrero JJ, Stenvinkel P, Cuppari L, Ikizler A, Kalantar-Zadeh K, Kaysen G, et al. Etiology of the Protein-Energy Wasting Syndrome in chronic kidney disease: A consensus statement from the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2013;23(2):77– 90.
Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant. 2018;33:iii35– iii40.
Wang DT, Yang YJ, Huang RH, Zhang ZH, Lin X. Myostatin activates the ubiquitin-proteasome and autophagy-lysosome system contributing to muscle wasting in chronic kidney disease. Oxid Med Cell Longev. 2015; 684965.
Sureshbabu A, Ryter SW, Choi ME. Oxidative stress and autophagy: crucial modulators of kidney disease. Redox Biol. 2015;4:208-14.
Dikic I. Proteosomal and autophagic degradation systems. Annu Rev Biochem. 2017;86:193– 224.
Wang XH, Mitch WE. Mechanism of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014;10(9):504–16.
Giglio J, Kamimura MA, Lamarca F, Rodrigues J, Santin F, Avesani CM. Association of Sarcopenia with Nutritional Parameters, Quality of Life, Hospitalization and Mortality Rates of Elderly Patients on Hemodialysis. J Ren Nutr. 2018;28(3):197-207.
Kojima G. Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2017;49(11):1989-97.
Fielding RA, Vellas B, Evans WJ, Bhansin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249-56.
Chen LK, Liu K, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asian: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95-101.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412-23.
Bohm C, Storsley L, Tangri N. The assessment of frailty in older people with chronic kidney disease. Curr Opin Nephrol Hypertens. 2015;24(6):498-04.
Ren H, Gong D, Jia F, Xu B, Liu Z. Sarcopenia in patients undergoing hemodialysis: incidence rate, risk factors and its effect on survival risk. Ren Fail. 2016;38(3):364–71.
Johansen KL. The frail dialysis population: a growing burden for the dialysis community. Blood Purif. 2015;40(4):288-92.
Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531-2.
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489-95.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):148-56.
Schlüssel MM, dos Anjos LA, de Vasconcellos MT, Kac G. References values of handgrip dinamometry of healthy adults: a population-based study. Clin Nutr. 2008;27(4):601-7.
Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. Espen guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017; 36(1):49– 64.
Hirai K, Ookawara S, Morishita Y. Sarcopenia and Physical Inactivity in Patients with chronic kidney disease. Nephrourol Mon. 2016;8(3):e37443.
Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Barany P, Heimbürger O, et al. Comparative associations of muscle mass and muscle strength with mortality in dyalisis patients. Clin J Am Soc Nephrol. 2014;9(10):1720– 8.
Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr. 2018; pii: S0261-5614(18)31344-X.
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F : a symptom score to predict persons with sarcopenia at risk of poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28 – 36.
Wallis SJ, Wall J, Biram RW, Romero-Ortuno R. Association of the clinical frailty scale with hospital outcomes. QJM. 2015;108(12):943–9.
Hartley P, Adamson J, Cunningham C, Embleton G, Romero-Ortuno R. Clinical frailty and functional trajectories in hospitalized older adults : A retrospective observational study. Geriatr Gerontol Int. 2017;17(7):1063 – 8.
Alfaadhel TA, Soroka SD, Kiberd BA, Landry D, Moorhouse P, Tennankore KK. Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Clin J Am Soc Nephrol. 2015;10(5):832-40.
Clark DA, Khan U, Kiberd BA, Turner CC, Dixon A, Landry D, et al. Frailty in end-stage renal disease: comparing patient, caregiver, and clinician perspectives. BMC Nephrol. 2017;18:148.
Iyasere OU, Brown EA, Johansson L, Huson L, Smee J, Maxwell AP, et al. Quality of Life and Physical Function in Older Patients on Dialysis: A Comparison of Assisted Peritoneal Dialysis with Hemodialysis. Clin J Am Soc Nephrol. 2016;11(3):423-30.
McAdams-DeMarco MA, Law A, Salter ML, Boyarsky B, Gimenez L, Jaar BG, et al. Frailty as a novel predictor of mortality and hospitalization in hemodialysis patients of all ages. J Am Geriatr Soc. 2013;61(6):896-01.
Johansen KL, Dalrymple LS, Delgado C, Chertow GM, Segal MR, Chiang J, et al. Factors associated with frailty and its trajectory among patients on hemodialysis. Clin J Am Soc Nephrol. 2017;12(7):1100-8.
Yoneki K, Kitagawa J, Hoshi K, Harada M, Watanabe T, Shimoda T, et al. Association between frailty and bone loss in patients undergoing maintenance hemodialysis. J Bone Miner Metab. 2018. [en prensa]
Deraz H, Mahmoud AA, Fouad M. Prevalence and correlates of frailty among patients on maintenance hemodialysis. Gen Med (Los Angel). 2015;3:156.
Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornark J, Grimes B, et al. Association between body composition and frailty among prevalent hemodialysis patients: A US Renal Data System special study. J Am Soc Nephrol. 2014;25(2):381-9.
Bancu I, Graterol F, Bonal J, Fernández-Crespo P, García J, Aguerrevere S, et al. Frail patient in hemodialysis: A new
challenge in nephrology - Incidence in our area, Barcelonès Nord and Maresme. J Aging Res. 2017:7624139.
Yadla M, John JP, Mummadi M. A study of clinical assessment of frailty in patients on maintenance hemodialysis supported by cashless government scheme. Saudi J Kidney Dis Transpl. 2017; 28(1):15-22.
Kutner NG, Zhang R, Huang Y, McClellan WM, Soltow QA, Lea J. Risk factors for frailty in a large prevalent cohort of hemodialysis patients. Am J Med Sci. 2014;348(4):277-82.
Johansen KL, Chertow GM, Jin C, Kutner NG. Significance of frailty among dialysis patiens. J Am Soc Nephrol. 2007;18(11):2960-7.
Hristea D, Deschamps T, Paris A, Lefrançois G, Collet V, Savoiu C, et al. Combining intra-dialytic exercise and nutritional supplementation in malnourished older haemodialysis patients: Towards better quality of life and autonomy. Nephrology (Carlton). 2016;21(9):785–90.
Martin-Alemañy G, Valdez-Ortiz R, Olvera-Soto G, Gomez-Guerrero I, Aguire-Esquivel G, Cantu-Quintanilla G, et al. The effects of resistance exercise and oral nutritional supplementation during hemodialysis on indicators of nutritional status and quality of life. 2016;31(10):1712-20.
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2020 Brian Wally Mariños Cotrina, Franco Salvador Rodríguez Brown Agurto, Daniel Fernando Mendez Carbajal
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.